InsidersTradesSigma
Browse the complete record of transactions filed by Schwartz Daniel Mark, Director. Officer active across 1 company, notably RxSight, Inc.. In total, 2 disclosures have been published. Activity tracked since 3 August 2021. The latest transaction was filed on 3 August 2021 (C). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Daniel Mark Schwartz is a Board Member at RxSight, Inc. He plays an important role in the company's governance, bringing his expertise in strategy and business development. His experience in the medical sector allows him to contribute to informed decision-making and ensure compliance with regulations. Daniel is also involved in evaluating market opportunities.